Panagene Inc
KOSDAQ:046210
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Panagene Inc
Total Current Assets
Panagene Inc
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Panagene Inc
KOSDAQ:046210
|
Total Current Assets
₩49.2B
|
CAGR 3-Years
30%
|
CAGR 5-Years
25%
|
CAGR 10-Years
17%
|
|
|
Celltrion Inc
KRX:068270
|
Total Current Assets
₩6.2T
|
CAGR 3-Years
28%
|
CAGR 5-Years
20%
|
CAGR 10-Years
19%
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Total Current Assets
₩56.5B
|
CAGR 3-Years
45%
|
CAGR 5-Years
102%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Total Current Assets
₩480.8B
|
CAGR 3-Years
49%
|
CAGR 5-Years
28%
|
CAGR 10-Years
34%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Total Current Assets
₩176.1B
|
CAGR 3-Years
30%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
Total Current Assets
₩39.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Panagene Inc
Glance View
PANAGENE Inc. engages in the molecular diagnostics business. The company is headquartered in Daejeon, Daejeon and currently employs 71 full-time employees. The company went IPO on 2000-08-16. The firm develops selective deoxyribonucleic acid (DNA) amplification technology and detection technology which used in the drug susceptibity testing, single nucleotide sequence variation inspection, infectious diseases hospital inspection and other DNA relates diseases inspection. The Company’s customs mainly include DAKO, AdvanDx, Abbott, LSI Medience Corporation and others.
See Also
What is Panagene Inc's Total Current Assets?
Total Current Assets
49.2B
KRW
Based on the financial report for Sep 30, 2025, Panagene Inc's Total Current Assets amounts to 49.2B KRW.
What is Panagene Inc's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
17%
Over the last year, the Total Current Assets growth was -36%. The average annual Total Current Assets growth rates for Panagene Inc have been 30% over the past three years , 25% over the past five years , and 17% over the past ten years .
